These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15755124)

  • 21. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
    Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
    Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
    Marciani DJ
    Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foamy matters: an update on
    Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
    Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syntheses and mucosal adjuvant activity of simplified oleanolic acid saponins possessing cinnamoyl ester.
    Shirahata T; Nagai T; Hirata N; Yokoyama M; Katsumi T; Konishi N; Nishino T; Makino K; Yamada H; Kaji E; Kiyohara H; Kobayashi Y
    Bioorg Med Chem; 2017 Mar; 25(6):1747-1755. PubMed ID: 28237555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a minimal saponin vaccine adjuvant based on QS-21.
    Fernández-Tejada A; Chea EK; George C; Pillarsetty N; Gardner JR; Livingston PO; Ragupathi G; Lewis JS; Tan DS; Gin DY
    Nat Chem; 2014 Jul; 6(7):635-43. PubMed ID: 24950335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting structure-activity relationships of QS-21 in the design and synthesis of streamlined saponin vaccine adjuvants.
    Ghirardello M; Ruiz-de-Angulo A; Sacristan N; Barriales D; Jiménez-Barbero J; Poveda A; Corzana F; Anguita J; Fernández-Tejada A
    Chem Commun (Camb); 2020 Jan; 56(5):719-722. PubMed ID: 31833496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Effect on Adjuvanticity of Saponins.
    Wang P; Ding X; Kim H; Michalek SM; Zhang P
    J Med Chem; 2020 Mar; 63(6):3290-3297. PubMed ID: 32101001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant activities of saponins from traditional Chinese medicinal herbs.
    Song X; Hu S
    Vaccine; 2009 Aug; 27(36):4883-90. PubMed ID: 19559122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of QS-21-based immunoadjuvants.
    Wang P; Dai Q; Thogaripally P; Zhang P; Michalek SM
    J Org Chem; 2013 Nov; 78(22):11525-34. PubMed ID: 24147602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity.
    Jiang ZH; Budzynski WA; Qiu D; Yalamati D; Koganty RR
    Carbohydr Res; 2007 May; 342(6):784-96. PubMed ID: 17300769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QS-21 structure/function studies: effect of acylation on adjuvant activity.
    Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
    Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulating macrophage activity in mice and humans by oral administration of quillaja saponin.
    Naknukool S; Horinouchi I; Hatta H
    Biosci Biotechnol Biochem; 2011; 75(10):1889-93. PubMed ID: 21979062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria.
    Kensil CR; Soltysik S; Wheeler DA; Wu JY
    Adv Exp Med Biol; 1996; 404():165-72. PubMed ID: 8957293
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of new immunoadjuvant saponin named QB-90, and analysis of its organ-specific distribution in Quillaja brasiliensis by HPLC.
    Fleck JD; de Costa F; Yendo AC; Segalin J; Dalla Costa TC; Fett-Neto AG; Gosmann G
    Nat Prod Res; 2013; 27(10):907-10. PubMed ID: 22404569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISCOMs and ISCOMATRIX.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
    Gilewski TA; Ragupathi G; Dickler M; Powell S; Bhuta S; Panageas K; Koganty RR; Chin-Eng J; Hudis C; Norton L; Houghton AN; Livingston PO
    Clin Cancer Res; 2007 May; 13(10):2977-85. PubMed ID: 17504999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
    Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M
    Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.